ARCHIVES

Amgen Website Invites Testimonials, Posts Off-Label Claims By Patients.

This article is from The Cancer Letter archive.

Vol. 33 No. 41 | November 9, 2007

Download PDF Visit The Full Archive

Related Articles

In Brief: FDA’s Tabor To Head Biological Carcinogenesis in DCE; Steve Larson to Leave NIH for Memorial

April 29, 1988

New Compounds To Treat Gleevec-Resistant CML

January 26, 2007

NCI Cooperative Group, Cancer Center Trials Listed

April 25, 2008

Harold Varmus Plans To Leave Presidency Of MSKCC

January 15, 2010

Paraplatin Lengthened TTP In HER2+ Advanced Breast Ca

January 31, 2003

Congress Close to Approving Appropriations for FY 1985

September 14, 1984